Literature DB >> 6420445

The effects of naloxone on hot flashes and gonadotropin secretion in postmenopausal women.

J DeFazio, C Verheugen, R Chetkowski, T Nass, H L Judd, D R Meldrum.   

Abstract

Hot flashes have a close temporal relationship with the initiation of LH pulses, suggesting that factors stimulating gonadotropin release are involved in the mechanism of this disturbance. It has been reported that the opiate antagonist naloxone acutely blocked subjective hot flashes, a seemingly paradoxical effect, since the use of this agent in premenopausal women increases the magnitude and frequency of LH pulses. We, therefore, studied the effects of naloxone in 16 postmenopausal women with frequent hot flashes using continuous recordings of finger temperature and skin resistance as objective indices of flushing and perspiration, respectively. After baseline recordings, the subjects were randomized into equal groups, and the recordings were repeated during 8-h infusion of either saline or naloxone (22 micrograms/min). Serum gonadotropin levels were measured at 15-min intervals before and during the last 4 h of the infusion. Naloxone did not change the rate of objectively measured hot flashes, mean serum LH or FSH levels, or the frequencies or amplitudes of gonadotropin pulses. These data suggest that there is a very low input of endogenous opiates on gonadotropin secretion in postmenopausal women and that opioid peptides do not play a role in the initiation of the postmenopausal hot flash.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6420445     DOI: 10.1210/jcem-58-3-578

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  12 in total

1.  Effects of opioid receptor blockade on luteinizing hormone (LH) pulses and interpulse LH concentrations in normal women during the early phase of the menstrual cycle.

Authors:  W S Evans; J Y Weltman; M L Johnson; A Weltman; J D Veldhuis; A D Rogol
Journal:  J Endocrinol Invest       Date:  1992 Jul-Aug       Impact factor: 4.256

Review 2.  Management of menopause when estrogen cannot be used.

Authors:  R L Young; N S Kumar; J W Goldzieher
Journal:  Drugs       Date:  1990-08       Impact factor: 9.546

Review 3.  [Prevention of secondary manifestations of menopause. Pathophysiologic principles].

Authors:  M H Birkhäuser
Journal:  Arch Gynecol Obstet       Date:  1989       Impact factor: 2.344

4.  Gonadal steroids do not affect basal growth hormone response to naloxone in humans.

Authors:  P Monteleone; M Maj; M Iovino; L Fiorenza; P M Fiumani; L Steardo
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

5.  Black cohosh has central opioid activity in postmenopausal women: evidence from naloxone blockade and positron emission tomography neuroimaging.

Authors:  Nancy E Reame; Jane L Lukacs; Vasantha Padmanabhan; Aimee D Eyvazzadeh; Yolanda R Smith; Jon-Kar Zubieta
Journal:  Menopause       Date:  2008 Sep-Oct       Impact factor: 2.953

Review 6.  Menopausal hot flashes: mechanisms, endocrinology, treatment.

Authors:  Robert R Freedman
Journal:  J Steroid Biochem Mol Biol       Date:  2013-09-04       Impact factor: 4.292

Review 7.  Effect of opioid antagonists on sex hormone secretion.

Authors:  H Tenhola; D Sinclair; H Alho; T Lahti
Journal:  J Endocrinol Invest       Date:  2011-12-15       Impact factor: 4.256

Review 8.  Physical activity and health during the menopausal transition.

Authors:  Barbara Sternfeld; Sheila Dugan
Journal:  Obstet Gynecol Clin North Am       Date:  2011-09       Impact factor: 2.844

9.  Anxiogenic CO2 stimulus elicits exacerbated hot flash-like responses in a rat menopause model and hot flashes in postmenopausal women.

Authors:  Lauren M Federici; Sarah Dorsey Roth; Connie Krier; Stephanie D Fitz; Todd Skaar; Anantha Shekhar; Janet S Carpenter; Philip L Johnson
Journal:  Menopause       Date:  2016-11       Impact factor: 2.953

10.  Short-term effects of ovariectomy: the opioid control of LH secretion in fertile climacteric and postmenopausal women.

Authors:  F Petraglia; G Comitini; G D'Ambrogio; A Volpe; F Facchinetti; G Alessandrini; A R Genazzani
Journal:  J Endocrinol Invest       Date:  1985-08       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.